Single-Stranded Silencing RNAs: Hit Rate and Chemical Modification
Publication: nucleic acid therapeutics
Volume 26, Issue Number 4
Abstract
Single-stranded silencing RNAs (ss-siRNAs) are chemically modified single-stranded oligomers that engage the RNA interference machinery normally used by duplex RNAs to silence gene expression. ss-siRNAs have the potential to combine advantages of antisense oligonucleotides and siRNAs. Previous work has explored the chemistry of the phosphate and the oligonucleotide body. We now describe the process of attempting to develop and optimize ss-siRNAs based on five active siRNA duplexes. Three of the sequences failed to show any activity as ss-siRNAs, and in two of those cases the ss-siRNAs showed significantly increased toxicity relative to the parent duplexes. For the two sequences that did work well as ss-siRNAs, we show that the chemistry of the 3′-terminal dinucleotide also has a significant effect on the potency of ss-siRNAs. Previously published work on ss-siRNAs has been based on a 2′-O-methoxyethyl-RNA (MOE) dinucleotide at the 3′-terminus. To our surprise, oligomers containing 2′-O-Me-RNA modifications at the 3′-terminus showed significantly improved potency and activity relative to those modified with MOE at the same sites. Oligonucleotides with two locked nucleic acid units at the 3′-terminus showed improved activity over the MOE-modified analog for one sequence. Importantly, the fact that 2′-O-Me-RNA works so well makes the ss-siRNA approach accessible to a wider range of researchers since it can be achieved with inexpensive commercially available modifications.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Watts JK and Corey DR. (2012). Silencing disease genes in the laboratory and the clinic. J Pathol 226:365–379.
2.
Ionis Pharmaceuticals. Pipeline. Available at www.ionispharma.com/pipeline (accessed on April 22, 2016).
3.
Prakash TP, Graham MJ, Yu J, Carty R, Low A, Chappell A, Schmidt K, Zhao C, Aghajan M, et al. (2014). Targeted delivery of antisense oligonucleotides to hepatocytes using tri-antennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Res 42:8796–8807.
4.
Lebleu B, Moulton HM, Abes R, Ivanova GD, Abes S, Stein DA, Iversen PL, Arzumanov AA and Gait MJ. (2007). Cell penetrating peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev 60:517–529.
5.
Prakash TP, Lima WF, Murray HM, Elbashir S, Cantley W, Foster D, Jayaraman M, Chappell AE, Manoharan M, Swayze EE and Crooke ST. (2013). Lipid nanoparticles improve activity of single-stranded siRNA and gapmer antisense oligonucleotides in animals. Acs Chem Biol 8:1402–1406.
6.
Lima WF, Prakash TP, Murray HM, Kinberger GA, Li WY, Chappell AE, Li CS, Murray SF, Gaus H, et al. (2012). Single-stranded siRNAs activate RNAi in animals. Cell 150:883–894.
7.
Yu D, Pendergraff H, Liu J, Kordasiewicz HB, Cleveland DW, Swayze EE, Lima WF, Crooke ST, Prakash TP and Corey DR. (2012). Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant Huntingtin expression. Cell 150:895–908.
8.
Prakash TP, Lima WF, Murray HM, Li W, Kinberger GA, Chappell AE, Gaus H, Seth PP, Bhat B, Crooke ST and Swayze EE. (2015). Identification of metabolically stable 5′-phosphate analogs that support single-stranded siRNA activity. Nucleic Acids Res 43:2993–3011.
9.
Hu J, Liu J, Yu D, Aiba Y, Lee S, Pendergraff H, Boubaker J, Artates JW, Lagier-Tourenne C, et al. (2014). Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs. Nucleic Acid Ther 24:199–209.
10.
Hu J, Liu J, Narayanannair KJ, Lackey JG, Kuchimanchi S, Rajeev KG, Manoharan M, Swayze EE, Lima WF, et al. (2014). Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs. Biochemistry 53:4510–4518.
11.
Liu J, Hu J, Hicks JA, Prakash TP and Corey DR. (2015). Modulation of splicing by single-stranded silencing RNAs. Nucleic Acid Ther 25:113–120.
12.
Matsui M, Prakash TP and Corey DR. (2013). Transcriptional silencing by single-stranded RNAs targeting a noncoding RNA that overlaps a gene promoter. ACS Chem Biol 8:122–126.
13.
Zhao T, Wu Z, Wang S and Chen L. (2014). Expression and function of natural antisense transcripts in mouse embryonic stem cells. Sci China Life Sci 57:1183–1190.
14.
Martin P. (1995). A new access to 2′-O-alkylated ribonucleosides and properties of 2′-O-alkylated oligoribonucleotides. Helv Chim Acta 78:486–504.
15.
Koshkin AA, Singh SK, Nielsen P, Rajwanshi VK, Kumar R, Meldgaard M, Olsen CE and Wengel J. (1998). LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron 54:3607–3630.
16.
Chillemi R, Greco V, Nicoletti VG and Sciuto S. (2013). Oligonucleotides conjugated to natural lipids: synthesis of phosphatidyl-anchored antisense oligonucleotides. Bioconj Chem 24:648–657.
17.
Koller E, Propp S, Murray H., Lima W, Bhat B, Prakash TP, Allerson CR, Swayze EE, Marcusson EG and Dean NM. (2006). Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res 2006 34:4467–4476.
18.
Allerson CR, Sioufi N, Jarres R, Prakash TP, Naik N, Berdeja A, Wanders L, Griffey RH, Swayze EE and Bhat B. (2005). Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 48:901–904.
19.
Janowski BA and Corey DR. (2010). Minireview: switching on progesterone receptor expression with duplex RNA. Mol Endocrinol 24:2243–2252.
20.
Janowski BA, Huffman KE, Schwartz JC, Ram R, Nordsell R, Shames DS, Minna JD and Corey DR. (2006). Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol 13:787–792.
21.
Younger ST and Corey DR. (2011). Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res 39:5682–5691.
22.
Watts JK, Yu D, Charisse K, Montaillier C, Potier P, Manoharan M and Corey DR. (2010). Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters. Nucleic Acids Res 38:5242–5259.
23.
Ramachandran S, Karp PH, Jiang P, Ostedgaard LS, Walz AE, Fisher JT, Keshavjee S, Lennox KA, Jacobi AM, et al. (2012). A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A 109:13362–13367.
24.
Yoshinari K, Miyagishi M and Taira K. (2004). Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res 32:691–699.
Information & Authors
Information
Published In

Copyright
Copyright 2016, Mary Ann Liebert, Inc.
History
Published in print: August 2016
Published online: 1 August 2016
Published ahead of print: 28 April 2016
Accepted: 16 March 2016
Received: 1 July 2015
Topics
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.